Resilience Therapeutics
Boston
About Resilience Therapeutics
Resilience Therapeutics is an operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions. The company develops therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders. Its drug discovery engine focuses on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress-Related Disorders, providing medical practitioners with therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders. Founded in 2014, Resilience Therapeutics is headquartered in Boston, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $3.4M
- Last round: Debt Financing (Mar 2016)
- Website: resiliencetx.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/resilience-therapeutics-195627 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.